Publication:
Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer

Simple item page
dc.contributor.authorGÜNEY ESKİLER, GAMZE
dc.contributor.authorÖZMAN, ZEYNEP
dc.contributor.institutionauthorÖZMAN, ZEYNEP
dc.date.accessioned2020-11-11T22:13:57Z
dc.date.available2020-11-11T22:13:57Z
dc.date.issued2020-06-09T00:00:00Z
dc.identifier.citationGÜNEY ESKİLER G., ÖZMAN Z., -Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer-, European Human Genetics Virtual Conference 2020, 6 - 09 Haziran 2020
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27371
dc.identifier.yoksis6447249
dc.titleImpact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.ida58fbd54-5d07-464d-8221-c29a03b8e657
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication14ea756c-5a6f-4c3b-86f7-4344ad265721
relation.isAuthorOfPublication.latestForDiscovery14ea756c-5a6f-4c3b-86f7-4344ad265721
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler